Standout Papers

FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. 2002 2026 2010 2018 600
  1. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases. (2002)
    Ryohei Furumai, Akihisa Matsuyama et al. PubMed

Immediate Impact

14 by Nobel laureates 39 from Science/Nature 80 standout
Sub-graph 1 of 21

Citing Papers

Targeted protein degradation: from mechanisms to clinic
2024 Standout
Cancers make their own luck: theories of cancer origins
2023 Standout

Works of Akito Tanaka being referenced

Selective degradation of splicing factor CAPERα by anticancer sulfonamides
2017
Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation
2014 Nobel

Author Peers

Author Last Decade Papers Cites
Akito Tanaka 2154 421 168 323 106 2.8k
Yuhong Du 1883 418 175 284 92 3.0k
Motonari Uesugi 2360 423 179 692 130 3.5k
Claudette Briand 2510 940 139 407 93 3.8k
Olli T. Pentikäinen 1496 205 256 430 100 3.0k
Hyo Jin Kang 1681 467 140 214 100 2.8k
Lajos Gera 1281 525 298 342 103 2.8k
Jiřı́ Jiráček 1663 397 172 569 105 2.6k
Rüdiger Woscholski 2974 409 225 251 73 4.1k
Russell Dahl 1653 348 439 472 71 2.7k
Ada Rephaeli 1814 558 167 265 88 2.6k

All Works

Loading papers...

Rankless by CCL
2026